Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. (LH) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a EV/FCF of 30.8×. Over the past ten years it has ranged from 9.1× (April 2021) to 48.9× (April 2015); the current reading is higher than 89% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.7× (1.68%)
FY2024 24.1× (25.59%)
FY2023 32.4× 111.03%
FY2022 15.3× 41.23%
FY2021 10.9× (10.50%)
FY2020 12.1× (37.53%)
FY2019 19.4× 13.72%
FY2018 17.1× 0.01%
FY2017 17.1× (0.08%)
FY2016 17.1× (20.87%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 27.8× 30.26%
Mar 2026 21.3× (10.06%)
Dec 2025 23.7× 4.06%
Sep 2025 22.8× (2.69%)
42 more quarters

Against its own ten years

Low 9.1× High 48.9×
Ten-year median 19.5×
Current reading's percentile 93

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on LH